Okay, let's tackle this question about Sodium Nitroprusside. The question is asking which statement is false about it. First, I need to recall the key points about Sodium Nitroprusside.

Core Concept: Sodium Nitroprusside is a vasodilator used in hypertensive emergencies. It acts as a direct-acting, rapid-onset, short-acting drug that causes smooth muscle relaxation by releasing nitric oxide. It affects both arteries and veins.

Now, the correct answer is the one that's not true. Let's think about the options. Common true statements about Sodium Nitroprusside include its use in hypertensive crises, rapid onset (within 1-2 minutes), and the need for careful monitoring due to cyanide toxicity risk. Also, it's usually administered intravenously and has a half-life of a few minutes.

If the options include something like "it's a beta-blocker," that's incorrect because it's a vasodilator. Another wrong option might be "it's used for long-term management," which is false since it's for acute situations. Another possible incorrect statement could be about its mechanism, like "it blocks calcium channels," which it doesn't; it releases nitric oxide.

Clinical Pearl: Remember that Sodium Nitroprusside can cause cyanide toxicity, especially with prolonged use, due to the cyanide ion in its structure. Monitoring for thiocyanate levels and ensuring adequate thiosulfate levels is important to prevent toxicity.

Putting this all together, the false statement would be one that contradicts these points. For example, if an option says it's a beta-blocker or used long-term, that's incorrect. The correct answer is the one that states any of these falsehoods.

**Core Concept** Sodium nitroprusside is a direct-acting vasodilator that releases nitric oxide (NO), causing rapid smooth muscle relaxation in arteries and veins. It is used for acute blood pressure control in hypertensive emergencies due to its rapid onset and short half-life.

**Why the Correct Answer is Right** The false statement is **Option B** ("It is contraindicated in patients with renal failure"). Sodium nitroprusside requires monitoring in renal failure because its metabolite, cyanide, is primarily excreted by the kidneys. Prolonged use can lead to cyanide toxicity, but it is not absolutely contraindicated. Clinicians must balance benefits with risks in such patients.

**Why Each Wrong Option is Incorrect**
**Option A:** "It causes venodilation and arterial dilation" is correct. Sodium nitroprusside acts on both venous and arterial beds, reducing preload and afterload.
**Option C:** "Onset of action is within 1-2 minutes" is correct. Its rapid onset makes it ideal for acute hypertension management.
**Option D:** "Metabolized to thiocyanate via rhodanese" is correct. The drug is broken down in the liver and tissues, producing thiocyanate, which is renally excreted.

**Clinical Pearl / High-Yield Fact** Cyanide toxicity from sodium nitroprusside is a critical concern, especially with prolonged infusion (>72 hours). Monitor thiocyanate levels and ensure adequate thiosulfate (a cyanide antidote) in patients

✓ Correct Answer: B. Drug of choice for Hypertensive emergency